PUMA BIOTECHNOLOGY INC (PBYI)

US74587V1070 - Common Stock

2.95  -0.17 (-5.45%)

After market: 3.056 +0.11 (+3.59%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
253.2M
12.48%
228M
-9.95%
235.637M
3.35%
228.41M
-3.07%
212.06M
-7.16%
210.87M
-0.56%
204M
-3.26%
198.9M
-2.50%
193.8M
-2.56%
188.7M
-2.63%
EBITDA
YoY % growth
11.9M
158.42%
32.72M
174.96%
44.784M
36.87%
34.68M
-22.56%
23.46M
-32.35%
19.38M
-17.39%
N/AN/AN/AN/A
EBIT
YoY % growth
1.3M
104.28%
23.8M
1,730.77%
33.265M
39.77%
23.766M
-28.56%
22.882M
-3.72%
19.074M
-16.64%
-1.02M
-105.35%
-9.69M
-850.00%
-19.38M
-100.00%
-28.05M
-44.74%
Operating Margin
0.51%10.44%14.12%10.40%10.79%9.05%-0.50%-4.87%-10.00%-14.86%
EPS
YoY % growth
-0.53
65.13%
0.00
100.00%
0.46
3,314,649,325,744,685,000.00%
0.31
-33.41%
0.35
13.10%
0.32
-8.73%
-0.01
-103.23%
-0.15
-1,400.00%
-0.31
-100.00%
-0.51
-66.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
0.09
-66.65%
Revenue
Q2Q % growth
53.55M
-25.83%
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
6.477M
-56.23%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.41
241.67%
0.360.0514.63%
Q2 2024
Q2Q % growth
-0.09
-280.00%
-0.130.0431.95%
Q1 2024
Q2Q % growth
-0.10
-433.33%
-0.220.1254.75%
Q4 2023
Q2Q % growth
0.26
316.67%
0.31-0.05-14.94%
Q3 2023
Q2Q % growth
0.12
1,300.00%
0.080.0453.45%
Q2 2023
Q2Q % growth
0.05
-76.19%
0.010.04553.59%
Q1 2023
Q2Q % growth
0.03
137.50%
-0.070.10142.02%
Q4 2022
Q2Q % growth
-0.12
-220.00%
0.05-0.17-335.29%
Q3 2022
Q2Q % growth
-0.01
98.89%
-0.060.0582.17%
Q2 2022
Q2Q % growth
0.21
261.54%
0.010.201,918.45%
Q1 2022
Q2Q % growth
-0.08
-120.00%
-0.170.0952.75%
Q4 2021
Q2Q % growth
0.10
126.32%
-0.090.19211.92%
Q3 2021
Q2Q % growth
-0.90
-13.92%
-0.32-0.58-183.10%
Q2 2021
Q2Q % growth
-0.13
-262.50%
-0.280.1553.02%
Q1 2021
Q2Q % growth
0.40
193.02%
0.090.31350.76%
Q4 2020
Q2Q % growth
-0.38
-31.03%
-0.32-0.06-19.32%
Q3 2020
Q2Q % growth
-0.79
-79.55%
-0.40-0.39-96.13%
Q2 2020
Q2Q % growth
0.08
108.25%
-0.300.38126.33%
Q1 2020
Q2Q % growth
-0.43
-65.38%
-0.790.3645.40%
Q4 2019
Q2Q % growth
-0.29 -0.490.2041.38%
Q3 2019
Q2Q % growth
-0.44 -0.720.2839.15%
Q2 2019
Q2Q % growth
-0.97 -0.96-0.01-0.53%
Q1 2019
Q2Q % growth
-0.26 -0.700.4462.69%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
80.5M
43.49%
72.063M8.437M11.71%
Q2 2024
Q2Q % growth
47.1M
-13.74%
45.594M1.506M3.30%
Q1 2024
Q2Q % growth
43.8M
-17.01%
41.871M1.929M4.61%
Q4 2023
Q2Q % growth
72.2M
9.93%
75.021M-2.821M-3.76%
Q3 2023
Q2Q % growth
56.1M
-1.75%
59.109M-3.009M-5.09%
Q2 2023
Q2Q % growth
54.6M
-8.27%
52.768M1.832M3.47%
Q1 2023
Q2Q % growth
52.775M
15.38%
50.626M2.149M4.24%
Q4 2022
Q2Q % growth
65.68M
18.64%
58.205M7.475M12.84%
Q3 2022
Q2Q % growth
57.1M
23.46%
51.476M5.624M10.93%
Q2 2022
Q2Q % growth
59.52M
11.50%
53.676M5.844M10.89%
Q1 2022
Q2Q % growth
45.74M
-53.41%
45.968M-228K-0.50%
Q4 2021
Q2Q % growth
55.36M
5.33%
48.11M7.25M15.07%
Q3 2021
Q2Q % growth
46.25M
-8.87%
54.378M-8.128M-14.95%
Q2 2021
Q2Q % growth
53.38M
-24.37%
54.058M-678K-1.25%
Q1 2021
Q2Q % growth
98.17M
91.66%
72.898M25.272M34.67%
Q4 2020
Q2Q % growth
52.56M
-16.47%
53.848M-1.288M-2.39%
Q3 2020
Q2Q % growth
50.75M
-9.94%
54.11M-3.36M-6.21%
Q2 2020
Q2Q % growth
70.58M
30.90%
59.373M11.207M18.88%
Q1 2020
Q2Q % growth
51.22M
-48.30%
45.826M5.394M11.77%
Q4 2019
Q2Q % growth
62.92M 61.157M1.763M2.88%
Q3 2019
Q2Q % growth
56.35M 61.606M-5.256M-8.53%
Q2 2019
Q2Q % growth
53.92M 54.035M-115K-0.21%
Q1 2019
Q2Q % growth
99.07M 68.592M30.478M44.43%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -74.24% 0% 15.96%
Revenue0% -25.12% 0% 2.73%